Literature DB >> 1270146

Maturation of intestinal defenses against peroral infection with group B coxsackievirus in mice.

R M Loria, N Shadoff, S Kibrick, S Broitman.   

Abstract

The intestinal tract of adult mice provides effective protection against peroral infection with group B coxsackievirus. This protective function consists of at least two separate components. One is a barrier effect that prevents virus from passing through the mucosal side of the gut into the circulation. It becomes clearly evident at 18 days of life and is present thereafter. The other is a clearance mechanism that acts to eliminate virus from the enteric tract after infection has occurred. This is first demonstrable at about 14 to 18 days and also persists. The appearance of these protective functions coincides with the known development of enzymatic and morphological changes in the gut associated with the transition from suckling to weanling.

Entities:  

Mesh:

Year:  1976        PMID: 1270146      PMCID: PMC420772          DOI: 10.1128/iai.13.5.1397-1401.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  The nature of the villi in the small intestine of the rat.

Authors:  S J BAKER; V I MATHAN; V CHERIAN
Journal:  Lancet       Date:  1963-04-20       Impact factor: 79.321

2.  The morphologic basis of antibody formation development during the neonatal period.

Authors:  R A BRIDGES; R M CONDIE; S J ZAK; R A GOOD
Journal:  J Lab Clin Med       Date:  1959-03

3.  Virus-tissue union and the pathogenesis of enterovirus infections.

Authors:  C M KUNIN
Journal:  J Immunol       Date:  1962-05       Impact factor: 5.422

4.  Preparation of intestine and other elongated specimens for histologic and immunofluorescent studies.

Authors:  R M Loria; S Kibrick; S A Broitman
Journal:  Am J Clin Pathol       Date:  1973-09       Impact factor: 2.493

5.  Peroral infection with group B coxsackievirus in the adult mouse: protective functions of the gut.

Authors:  R M Loria; S Kibrick; S A Broitman
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

6.  Peroral infection with group B coxsackievirus in the newborn mouse: a model for human infection.

Authors:  R M Loria; S Kibrick; S A Broitman
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

7.  Selective absorption of macromolecules into intestinal epithelium and blood by neonatal mice.

Authors:  J G Lecce
Journal:  J Nutr       Date:  1972-01       Impact factor: 4.798

8.  Complex changes in the suckling rat's small intestine by the end of the 3d week of life.

Authors:  K Baintner; B Veress
Journal:  Experientia       Date:  1970-01-15

9.  Fine structure of the free cell surface in developing mouse intestinal mucosa.

Authors:  J Overton
Journal:  J Exp Zool       Date:  1965-07

10.  Cell dynamics in the intestine of the mouse from late fetal life to maturity.

Authors:  T M O'Connor
Journal:  Am J Anat       Date:  1966-03
View more
  3 in total

1.  In-utero coxsackievirus B4 infection of the mouse thymus.

Authors:  H Jaïdane; A Halouani; H Jmii; F Elmastour; S Abdelkefi; G Bodart; H Michaux; T Chakroun; F Sane; M Mokni; V Geenen; D Hober; M Aouni
Journal:  Clin Exp Immunol       Date:  2016-11-29       Impact factor: 4.330

2.  Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.

Authors:  Shaukat Khan; Hidemi Toyoda; Melissa Linehan; Akiko Iwasaki; Akio Nomoto; Günter Bernhardt; Jeronimo Cello; Eckard Wimmer
Journal:  J Gen Virol       Date:  2014-04-30       Impact factor: 3.891

3.  Expression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral route.

Authors:  Jieyan Pan; Lili Zhang; Matthew A Odenwald; Le Shen; Jerrold R Turner; Jeffrey M Bergelson
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.